Patent directory · USPTO A61K / A61P
Patents matching “Protagonist Therapeutics, Inc.”
32 pharma patents match "Protagonist Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 32 pharmaceutical patents matching "Protagonist Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12269856
Hepcidin analogues and uses thereof
granted -
US 12234300
Conjugated hepcidin mimetics
granted -
US 12018057
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 11939361
Compositions of peptide inhibitors of Interleukin-23 receptor
granted -
US 11884748
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted -
US 11845808
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 11840581
α4β7 thioether peptide dimer antagonists
granted -
US 11807674
Hepcidin analogues and uses thereof
granted -
US 11753443
Conjugated hepcidin mimetics
granted -
US 11472842
Analogues of hepcidin mimetics with improved in vivo half lives
granted -
US 11111272
α4α7 peptide monomer and dimer antagonists
granted -
US 11041000
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 10941183
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted -
US 10787490
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 10729676
Opioid agonist peptides and uses thereof
granted -
US 10626146
α4β7 thioether peptide dimer antagonists
granted -
US 10501515
Hepcidin analogues and uses thereof
granted -
US 10442846
Hepcidin analogues and uses thereof
granted -
US 10407468
Methods for synthesizing α4β7 peptide antagonists
granted -
US 10301371
Cyclic monomer and dimer peptides having integrin antagonist activity
granted -
US 10278957
Opioid agonist peptides and uses thereof
granted -
US 10196424
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted -
US 10059744
α4β7 thioether peptide dimer antagonists
granted -
US 10035824
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted